15.09.2024, 719 Zeichen

Valneva: Valneva, an Austrian/French specialty vaccine company, issued 23 million new ordinary shares at a price of €2.66 per Offer Share to certain categories of investors via a private placement through an accelerated bookbuilding process starting immediately. The company intends to use the net proceeds of the Private Placement primarily to fund the continuing development of the Company’s clinical programs which include notably the Phase 3 pediatric and Phase 4 programs for the chikungunya vaccine as well as the anticipated Phase 2 programs for the Shigella and Zika vaccine candidates. 
Valneva: weekly performance: -2.53%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (13/09/2024)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1199: ATX schwächer, Sommerloch als Beleidigung, oekostrom-Season startet, Bawag-Serie und am Ende Only You

Bildnachweis

Aktien auf dem Radar:Porr, Flughafen Wien, AT&S, Austriacard Holdings AG, RHI Magnesita, EuroTeleSites AG, voestalpine, SBO, EVN, Österreichische Post, FACC, Bajaj Mobility AG, CA Immo, Uniqa, Polytec Group, Frauenthal, RBI, Semperit, Wienerberger, BTV AG, BKS Bank Stamm, Josef Manner & Comp. AG, Amag, Bawag, CPI Europe AG, Telekom Austria, UBM.

---